Dr Stephen D. Nimer Named Researcher of the Year
October 30th 2023BioFlorida, a statewide association for Florida’s life sciences industry, has named Stephen D. Nimer, MD, director of Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, “Researcher of the Year.”
Dr Krill-Jackson on the Practice-Changing Effect of T-DXd in HER2+ Breast Cancer
October 12th 2023Elisa Krill-Jackson, MD, highlights the practice-changing effects of fam-trastuzumab deruxtecan-nxki in metastatic, HER2-positive breast cancer, as well as whether there is still a role for trastuzumab emtansine in this setting.
Researcher Leads NCI Grant to Develop Urine Test for Noninvasive Detection of Prostate Cancer
August 24th 2023Sanoj Punnen, MD, the University of Miami Miller School of Medicine, is leading a $2.5 million, five-year National Cancer Institute grant to explore a new way to noninvasively detect prostate cancer.
FDA Approval Insights: Quizartinib in Newly Diagnosed, FLT3-ITD+ AML
August 21st 2023Dr Sekeres discusses the FDA approval of quizartinib plus chemotherapy in patients with newly diagnosed, FLT3-ITD–positive AML, key efficacy and safety data from the QuANTUM-First trial, and how this quizartinib regimen addresses an unmet need for older patients in this population.
Trent Breaks Down Mutation Testing and ctDNA Monitoring in GIST
August 17th 2023Dr Trent discusses the need for improved awareness around mutation testing in GIST, the limitations of current clinical trial criteria, and the potential for ctDNA to become a longitudinal cancer monitoring tool, helping to prevent invasive means of measuring disease progression.
Trent Talks Through Potential Clinical Applications and Future Directions for MRD in GIST
July 31st 2023Dr Trent discusses the current role and significance of using MRD in gastrointestinal stromal tumor, current guidelines around mutation testing, and research seeking to expand the targeted therapy armamentarium.
World-Renowned Biochemist Joins Sylvester Comprehensive Cancer Center
July 17th 2023One of the world’s foremost biochemists is joining Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, bringing decades of groundbreaking research in genetics, epigenetics and cellular processes.
Sylvester Cancer Researcher Honored with ASCO Early Career Award
July 14th 2023Shria Kumar, MD, a colorectal cancer researcher with Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, has been awarded a Conquer Cancer Career Development Award from the American Society of Clinical Oncology.
Dr Taylor on the Integration of Tagraxofusp Into the Frontline Treatment Armamentarium for BPDCN
April 10th 2023Justin W. Taylor, MD, discusses the evolution of frontline treatment options for patients with blastic plasmacytoid dendritic cell neoplasm, including the integration of tagraxofusp-erzs into the treatment armamentarium in this disease space.
Dr. Beitinjaneh on the Evaluation of Tabelecleucel in EBV+ Hematologic Malignancies
February 27th 2023Amer M. Beitinjaneh, MD, discusses updated results from phase 3 ALLELE trial investigating the use of tabelecleucel in Epstein-Barr Virus–positive post-transplant lymphoproliferative disease following allogeneic hematopoietic stem cell transplant or solid organ transplant after failure of rituximab with or without chemotherapy.
Jaime Merchán, MD, Named Sylvester’s Translational and Clinical Oncology Research Program Co-Leader
February 21st 2023Jaime Merchán, MD, is the new Translational and Clinical Oncology Research Program co-leader at Sylvester Comprehensive Cancer Center, part of UHealth – University of Miami Health System.
Powerful AI Algorithm Provides New Insights into Deadly Glioblastoma and Other Cancers
February 10th 2023An international research group, led by scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has developed a new machine learning algorithm that can combine large datasets from multiple sources to pinpoint kinases and potentially target them for treatment.
D'Amato Discusses Research and Resistance Mechanisms in Sarcoma and Gastrointestinal Stromal Tumor
February 9th 2023Dr D’Amato discusses research in sarcoma and gastrointestinal stromal tumor, incorporating circulating tumor DNA analysis into routine reevaluation of patients with progressive disease, and the importance of establishing a drug’s clinical profile in non–trial target ethnic populations.
Sylvester Receives Approval to Build World-Class Myeloma Research Institute
January 18th 2023With three years to go, C. Ola Landgren, MD, PhD, is on track to establish a “top three” U.S. myeloma program within five years, with the announcement of the new, dedicated Myeloma Research Institute within Sylvester Comprehensive Cancer Center.
Sylvester Researchers Focus on Understanding Role of H. pylori in Gastric Cancer
November 30th 2022Helicobacter pylori infection is a major cause of gastric cancer, and researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have several projects underway to better understand the association and develop much-needed prevention and treatment.
Sylvester Scientists Discover a New Therapeutic Target to Treat Deadly Breast Cancer
November 22nd 2022Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown that a protein complex that governs gene expression sometimes gets rewired during breast cancer to help estrogen receptor positive tumors resist endocrine therapies and become more aggressive.
Azacitidine-Based Combinations Represent New Treatment Possibilities in MDS
Mikkael A. Sekeres, MD, MS, discussed the changes to the classifications of MDS, the evolution of targeted therapies for patients with acute myeloid leukemia, and approaches for patients with bone marrow failure syndromes.